Ignite Creation Date:
2024-05-06 @ 6:09 PM
Last Modification Date:
2024-10-26 @ 2:43 PM
Study NCT ID:
NCT05568680
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2022-09-28
Brief Title:
SynKIR-110 for Mesothelin Expressing Ovarian Cancer Cholangiocarcinoma or Mesothelioma
Sponsor:
Verismo Therapeutics
Organization:
Verismo Therapeutics
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Mesothelioma Malignant |
| Ovarian Cancer |
| Cholangiocarcinoma Recurrent |
Keywords: